Skip to main content

Kelch Mutations in Plasmodium falciparum Protein K13 Do Not Modulate Dormancy after Artemisinin Exposure and Sorbitol Selection In Vitro.

Publication ,  Journal Article
Breglio, KF; Rahman, RS; Sá, JM; Hott, A; Roberts, DJ; Wellems, TE
Published in: Antimicrobial agents and chemotherapy
May 2018

Some Kelch mutations of the Plasmodium falciparum K13 protein confer increased survival to dihydroartemisinin (DHA)-treated ring-stage parasites. Here, we asked if K13 mutations affect a dormancy phenotype allowing parasites to survive DHA exposure and then sorbitol selection. Although recrudescence from dormancy differed between two distinct parasite lines, it was similar for isogenic lines carrying single-site substitutions in K13. Therefore, K13 mutations do not alter the DHA-sorbitol combined dormancy phenotype; rather, traits from other loci likely determine this phenotype.

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Antimicrobial agents and chemotherapy

DOI

EISSN

1098-6596

ISSN

0066-4804

Publication Date

May 2018

Volume

62

Issue

5

Start / End Page

e02256 / e02217

Related Subject Headings

  • Sorbitol
  • Polymorphism, Genetic
  • Plasmodium falciparum
  • Mutation
  • Microbiology
  • Drug Resistance
  • Artemisinins
  • Antimalarials
  • Animals
  • 3214 Pharmacology and pharmaceutical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Breglio, K. F., Rahman, R. S., Sá, J. M., Hott, A., Roberts, D. J., & Wellems, T. E. (2018). Kelch Mutations in Plasmodium falciparum Protein K13 Do Not Modulate Dormancy after Artemisinin Exposure and Sorbitol Selection In Vitro. Antimicrobial Agents and Chemotherapy, 62(5), e02256–e02217. https://doi.org/10.1128/aac.02256-17
Breglio, Kimberly F., Rifat S. Rahman, Juliana M. Sá, Amanda Hott, David J. Roberts, and Thomas E. Wellems. “Kelch Mutations in Plasmodium falciparum Protein K13 Do Not Modulate Dormancy after Artemisinin Exposure and Sorbitol Selection In Vitro.Antimicrobial Agents and Chemotherapy 62, no. 5 (May 2018): e02256–e02217. https://doi.org/10.1128/aac.02256-17.
Breglio KF, Rahman RS, Sá JM, Hott A, Roberts DJ, Wellems TE. Kelch Mutations in Plasmodium falciparum Protein K13 Do Not Modulate Dormancy after Artemisinin Exposure and Sorbitol Selection In Vitro. Antimicrobial agents and chemotherapy. 2018 May;62(5):e02256–e02217.
Breglio, Kimberly F., et al. “Kelch Mutations in Plasmodium falciparum Protein K13 Do Not Modulate Dormancy after Artemisinin Exposure and Sorbitol Selection In Vitro.Antimicrobial Agents and Chemotherapy, vol. 62, no. 5, May 2018, pp. e02256–e02217. Epmc, doi:10.1128/aac.02256-17.
Breglio KF, Rahman RS, Sá JM, Hott A, Roberts DJ, Wellems TE. Kelch Mutations in Plasmodium falciparum Protein K13 Do Not Modulate Dormancy after Artemisinin Exposure and Sorbitol Selection In Vitro. Antimicrobial agents and chemotherapy. 2018 May;62(5):e02256–e02217.

Published In

Antimicrobial agents and chemotherapy

DOI

EISSN

1098-6596

ISSN

0066-4804

Publication Date

May 2018

Volume

62

Issue

5

Start / End Page

e02256 / e02217

Related Subject Headings

  • Sorbitol
  • Polymorphism, Genetic
  • Plasmodium falciparum
  • Mutation
  • Microbiology
  • Drug Resistance
  • Artemisinins
  • Antimalarials
  • Animals
  • 3214 Pharmacology and pharmaceutical sciences